C07D 223/04
With only hydrogen atoms, halogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly
Official title: with only hydrogen atoms, halogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
C07D223/04 (With only hydrogen atoms, halogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly) appears on 232 US grants and 248 published applications in this corpus.
Search patents in C07D- Granted patents
- 232
- Published applications
- 248
- Assignees
- 173
- Inventors
- 683
- Latest grant
- 17 Feb 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 3 | 0 |
| 1977 | 5 | 0 |
| 1978 | 6 | 0 |
| 1979 | 3 | 0 |
| 1980 | 5 | 0 |
| 1981 | 3 | 0 |
| 1982 | 1 | 0 |
| 1983 | 3 | 0 |
| 1984 | 0 | 0 |
| 1985 | 3 | 0 |
| 1986 | 4 | 0 |
| 1987 | 2 | 0 |
| 1988 | 2 | 0 |
| 1989 | 8 | 0 |
| 1990 | 1 | 0 |
| 1991 | 4 | 0 |
| 1992 | 2 | 0 |
| 1993 | 2 | 0 |
| 1994 | 0 | 0 |
| 1995 | 2 | 0 |
| 1996 | 2 | 0 |
| 1997 | 2 | 0 |
| 1998 | 0 | 0 |
| 1999 | 2 | 0 |
| 2000 | 1 | 0 |
| 2001 | 3 | 0 |
| 2002 | 2 | 2 |
| 2003 | 2 | 4 |
| 2004 | 4 | 6 |
| 2005 | 0 | 5 |
| 2006 | 6 | 9 |
| 2007 | 2 | 7 |
| 2008 | 3 | 3 |
| 2009 | 4 | 6 |
| 2010 | 4 | 7 |
| 2011 | 2 | 12 |
| 2012 | 4 | 12 |
| 2013 | 8 | 14 |
| 2014 | 12 | 13 |
| 2015 | 8 | 18 |
| 2016 | 13 | 14 |
| 2017 | 18 | 11 |
| 2018 | 8 | 9 |
| 2019 | 7 | 10 |
| 2020 | 8 | 16 |
| 2021 | 6 | 13 |
| 2022 | 15 | 16 |
| 2023 | 12 | 14 |
| 2024 | 5 | 9 |
| 2025 | 7 | 13 |
| 2026 | 3 | 5 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Methods and compositions for targeting Tregs using CCR8 inhibitors17 Feb 2026US 12,552,753 B2Nanjing Immunophage Biomedical Co., Ltd.
- Oxygenated and amino- or ammonium-containing phosphonic acid derivatives and their medical use20 Jan 2026US 12,528,775 B2Gri Bio, Inc.
- Compound as voltage-gated sodium channel inhibitor13 Jan 2026US 12,521,399 B2Guangzhou Fermion Technology Co., Ltd.
- Compositions and methods for carbon dioxide capture4 Nov 2025US 12,458,920 B2The Board of Trustees of the University of Illinois
- 3-diarylmethylenes and uses thereof26 Aug 2025US 12,398,103 B2Atux Iskay LLC
- Dpp1 inhibitors with polycyclic linkers and uses thereof10 Sep 2026US 2026/0265207 A1Insmed Incorporated
- Compound as voltage-gated sodium channel inhibitor3 Sep 2026US 2026/0257996 A1Guangzhou Fermion Technology Co., Ltd.
- Novel inhibitors of dna damage responses for cancer therapy23 Jul 2026US 2026/0209193 A1The Regents of the University of California
- Cationic lipids and preparation method thereof16 Jul 2026US 2026/0200849 A1RiboX Therapeutics HK Limited
- Charged Ion Channel Blockers And Methods For Use5 Mar 2026US 2026/0060989 A1Nocion Therapeutics, Inc.
Most cited
By later US patents
- Heterocyclo inhibitors of potassium channel function120US 7,005,436 B2Bristol-Myers Squibb Company · 2006
- Peptidyl inhibitors of viral proteases52US 5,866,684 AHoffmann-La Roche Inc. · 1999
- Amino acid derivatives51US 6,018,020 AHoffman-La Roche Inc. · 2000
- 1-Triarylalkyl-4-phenyl-4-piperidine carboxylic acids and derivatives43US 4,066,654 AG. D. Searle & Co. · 1978
- 1-(3,3,3-Triarylalkyl)-4-phenyl-piperidinealkanols35US 4,072,686 AG. D. Searle & Co. · 1978